BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 33475151)

  • 1. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003032. PubMed ID: 16235312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007783. PubMed ID: 32609387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Ramaratnam S; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001909. PubMed ID: 32196639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD001769. PubMed ID: 30091458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
    Brigo F; Igwe SC; Bragazzi NL; Lattanzi S
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013028. PubMed ID: 35187637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD005612. PubMed ID: 35349176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic drug management for febrile seizures in children.
    Offringa M; Newton R; Nevitt SJ; Vraka K
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003031. PubMed ID: 34131913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
    Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.